The stoichiometry of antibody-mediated neutralization and enhancement of west nile virus infection

被引:240
作者
Pierson, Theodore C.
Xu, Qing
Nelson, Steevenson
Oliphant, Theodore
Nybakken, Grant E.
Fremont, Daved H.
Diamond, Michael S.
机构
[1] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
D O I
10.1016/j.chom.2007.03.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antibody binding to the icosahedral arrangement of envelope proteins on the surface of flaviviruses can result in neutralization or enhancement of infection. We evaluated how many antibodies must bind to a given epitope on West Nile virus (WNV) to achieve neutralization. The most potent monoclonal antibodies (mAbs) block infection at concentrations that result in low occupancy of accessible sites on the virion, with neutralization occurring when as few as 30 of 180 envelope proteins are bound. In contrast, weakly neutralizing mAbs recognize fewer sites on the virion and require almost complete occupancy to inhibit WNV infection. For all mAbs studied, enhancement of infection is possible in cells bearing activating Fc-gamma receptors when the number of mAbs docked to the virion is not sufficient for neutralization. Thus, neutralization is best described by a model requiring "multiple hits" with the cumulative functional outcome determined by interplay between antibody affinity and epitope accessibility.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 66 条
  • [1] Mutational evidence for an internal fusion peptide in flavivirus envelope protein E
    Allison, SL
    Schalich, J
    Stiasny, K
    Mandl, CW
    Heinz, FX
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (09) : 4268 - 4275
  • [2] Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367
  • [3] ANTIBODY-MEDIATED EARLY DEATH INVIVO AFTER INFECTION WITH YELLOW-FEVER VIRUS
    BARRETT, ADT
    GOULD, EA
    [J]. JOURNAL OF GENERAL VIROLOGY, 1986, 67 : 2539 - 2542
  • [4] Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein
    Beasley, DWC
    Barrett, ADT
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (24) : 13097 - 13100
  • [5] Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice
    Ben-Nathan, D
    Lustig, S
    Tam, G
    Robinzon, S
    Segal, S
    Rager-Zisman, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) : 5 - 12
  • [6] Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein
    Bhardwaj, S
    Holbrook, M
    Shope, RE
    Barrett, ADT
    Watowich, SJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (08) : 4002 - 4007
  • [7] The molecular biology of West Nile virus: A new invader of the Western hemisphere
    Brinton, MA
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2002, 56 : 371 - 402
  • [8] Burton DR, 2001, CURR TOP MICROBIOL, V260, P109
  • [9] CYCLOPHOSPHAMIDE-POTENTIATED WEST NILE VIRAL ENCEPHALITIS - RELATIVE INFLUENCE OF CELLULAR AND HUMORAL-FACTORS
    CAMENGA, DL
    NATHANSON, N
    COLE, GA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (06) : 634 - 641
  • [10] Ceausu Em., 1997, Romanian Journal of Virology, V48, P3